This study is the first, to our knowledge, to report that EZH2 mRNA is downregulated in HNSCC owing to DNA methylation; this may be a critical event in HNSCC progression, which is associated with decreased survival. The gene discussed is EZH2; the disease is head and neck squamous cell carcinoma.